Small study looks only at a cardiac biomarker; findings are in line with reduced myocarditis risk in mRNA COVID vaccines ...

Moderna (MRNA), with its widely used COVID-19 vaccine, rose to prominence during the global pandemic. The stock soared an eye ...

Moderna is backing the American Lung Association’s (ALA’s) call for people with lung diseases to get vaccinated for the ...

Within the paediatric age group with access to vaccines, cumulative rates of Covid-19-associated hospitalisations were ...

Moderna said on Wednesday it would stop developing its experimental vaccine to prevent cytomegalovirus, a virus that can ...

Moderna has decided to halt the development of its mRNA-1647 vaccine for congenital cytomegalovirus (CMV) infections – once ...

A key question for investors going forward will be whether Moderna's other latent virus vaccines for Epstein-Barr and ...

It's a significant setback for the Cambridge company, which is already facing pressure from Wall Street and the federal government.

While development has been scrapped in CMV, a Phase II trial investigating the candidate in bone marrow transplant patients ...

Modernas Updated COVID-19 Vaccine Essential Against Emerging Variants KDCA Contracts 2.02 Million Moderna Doses for 2025-2026 ...

In this week’s edition of InnovationRx, we look Nvidia’s collaborations in life sciences and drug development, Cobot’s ...

Director Luigi Fassi explains how the fair has grown into a cornerstone of Italy’s contemporary art ecosystem by being ...